Skip to content

Article: Nicotinamide Riboside Supports Mitochondrial Health and Neurogenesis in ALS: Preclinical Findings

Nicotinamide Riboside Supports Mitochondrial Health and Neurogenesis in ALS: Preclinical Findings


Synopsis

Amyotrophic lateral sclerosis (ALS) is a disease where motor neurons progressively degenerate, leading to muscle weakness and paralysis. Declines in NAD+ contribute to mitochondrial dysfunction, toxic protein accumulation, and impaired neural stem cell activity in the brain. In a mouse model of ALS, oral nicotinamide riboside (NR), a precursor to NAD+, improved endurance and enhanced the clearance of toxic mitochondrial SOD1 protein. NR also activated mitochondrial stress response pathways, supported mitochondrial function, and increased proliferation and migration of neural stem and progenitor cells, although it did not delay disease onset or extend lifespan. These findings suggest that NR can help restore NAD+ metabolism, improve mitochondrial proteostasis, and promote neurogenesis in ALS.

Journal

International Journal of Biological Sciences

Read more

Neurological Health

Increasing NAD+ with Nicotinamide Riboside Protects Neurons in Spinocerebellar Ataxia Type 7: Preclinical Findings

Synopsis Spinocerebellar ataxia type 7 (SCA7) is a genetic disorder that damages the cerebellum and impairs movement. Researchers found that in SCA7 mice, key genes controlling calcium in cerebell...

Read more
Cardiovascular Disease

Nicotinamide Riboside Prevents Hearing Loss in Cockayne Syndrome: Preclinical Findings

Synopsis Age-related hearing loss (ARHL) is one of the most common disorders affecting elderly individuals. There is an urgent need for effective preventive measures for ARHL because none are curr...

Read more